{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:07:05Z","timestamp":1784297225704,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.exer.2026.111131","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:46:40Z","timestamp":1782431200000},"page":"111131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibitory effect of the water-soluble retinoid X receptor partial agonist CAt-PMN on allergic conjunctivitis-like responses in mice"],"prefix":"10.1016","volume":"270","author":[{"given":"Atsushi","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Pflugfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.111131_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/2040622315612745","article-title":"Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management","volume":"7","author":"Ackerman","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.exer.2026.111131_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/mai.2001.117591","article-title":"Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms","volume":"108","author":"Ahluwalia","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.67.4.31","article-title":"Rexinoid NEt-3IB promotes resident macrophage gene expression and mitigates desiccation-induced ocular surface disease","volume":"67","author":"Alam","year":"2026","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111131_bib5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: a systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2026.111131_bib6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1067\/mai.2000.110930","article-title":"Tear and conjunctival changes during the allergen-induced early- and late-phase responses","volume":"106","author":"Bacon","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib7","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00417-013-2333-4","article-title":"Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model","volume":"251","author":"Barequet","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111131_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2019.11.014","article-title":"ICON: diagnosis and management of allergic conjunctivitis","volume":"124","author":"Bielory","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib9","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1167\/iovs.13-13025","article-title":"The influence of genetic background on conventional outflow facility in mice","volume":"54","author":"Boussommier-Calleja","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111131_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/ACI.0b013e32830e6b3a","article-title":"Late-phase reaction in ocular allergy","volume":"8","author":"Choi","year":"2008","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib11","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/med.21578","article-title":"A review of the molecular design and biological activities of RXR agonists","volume":"39","author":"de Almeida","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.exer.2026.111131_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2019.01.015","article-title":"Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice","volume":"314","author":"Dheer","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.exer.2026.111131_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","article-title":"A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis","volume":"25","author":"Ebihara","year":"2009","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2026.111131_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12931-017-0507-z","article-title":"Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma","volume":"18","author":"Fujii","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.exer.2026.111131_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement","volume":"98","author":"Fukushima","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111131_bib16","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1096\/fj.201801805R","article-title":"Dietary \u03c9-3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating Th2 immune responses","volume":"33","author":"Hirakata","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.exer.2026.111131_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00003226-200001000-00017","article-title":"The role of nitric oxide in experimental allergic conjunctivitis","volume":"19","author":"Ko","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2026.111131_bib18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Kouro","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2020.06.004","article-title":"Epidemiological aspects of allergic conjunctivitis","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol. Int."},{"key":"10.1016\/j.exer.2026.111131_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12931-018-0963-0","article-title":"A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation","volume":"20","author":"Morichika","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.exer.2026.111131_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/med-2017-0034","article-title":"Model for studying anti-allergic drugs for allergic conjunctivitis in animals","volume":"12","author":"Nakazawa","year":"2017","journal-title":"Open Med."},{"key":"10.1016\/j.exer.2026.111131_bib22","article-title":"A mouse model of allergic conjunctivitis permitting tear eosinophil quantification","volume":"118","author":"Ogura","year":"2022","journal-title":"J. Phamaccol. Toxicol. Method."},{"key":"10.1016\/j.exer.2026.111131_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","article-title":"Steroid-induced glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J. Curr. Glaucoma Pract."},{"key":"10.1016\/j.exer.2026.111131_bib24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/ijms23020854","article-title":"Relationships between intraocular pressure, effective filtration area, and morphological changes in the trabecular meshwork of steroid-induced ocular hypertensive mouse eyes","volume":"23","author":"Ren","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2 Suppl. 2","key":"10.1016\/j.exer.2026.111131_bib25","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib26","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bmcl.2019.05.050","article-title":"3H-Imidazo[4,5-b]pyridine-6-carboxylic acid derivatives as rexinoids with reduced teratogenicity","volume":"29","author":"Takamura","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.exer.2026.111131_bib27","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/ATVBAHA.106.139089","article-title":"Histamine upregulates the expression of inducible nitric oxide synthase in human intimal smooth muscle cells via histamine H1 receptor and NF-\u03baB signaling pathway","volume":"27","author":"Tanimoto","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2026.111131_bib28","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0091-6749(96)70204-X","article-title":"Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure","volume":"97","author":"Tomassini","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2026.111131_bib29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2026.111131_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/840194","article-title":"Involvement of the retinoid X receptor ligand in the anti-inflammatory effect induced by peroxisome proliferator-activated receptor \u03b3 agonist in vivo","volume":"2011","author":"Yamamoto","year":"2011","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2026.111131_bib31","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1172\/JCI69774","article-title":"Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma","volume":"124","author":"Zode","year":"2014","journal-title":"J. Clin. Investig."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:40:17Z","timestamp":1784295617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526002873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0014483526002873"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111131","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effect of the water-soluble retinoid X receptor partial agonist CAt-PMN on allergic conjunctivitis-like responses in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111131"}}